In addition, beginning with the fall 2001 issue, the journal will put together theme-oriented issues. "The fall issue later this year will be focused on interventions in geriatric psychiatry, pharmacotherapy, psychosocial interventions, and ECT," Jeste said. In addition, guest editorials are planned including ones written by Thomas Laughren, M.D., team leader for psychiatric drug products in FDA’s division of neuropharmacological drug products, and Stephen Hyman, M.D., director of the National Institute of Mental Health.